5UKPDS Study Group.Overview of six years therapy of type 2 diabetes a progressive disease (UKPDS 16)[J].Diabetes Care,1995,44(11):1249.
6Turner RC,Cull CA,Frighi V,et al.Glycemic control with diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus:progressive requirement for multiple,therapies (UKPDS49) UK prospective diabetes study(UKPDS) Group[J].JAMA,1999,281(21):2005.
7Sivitz WL.Lipotoxicity and glucotoxicity in type 2 diabetes.Effects on development and progression[J].Postgrad Med,2001,109(4):55.
9Monnier L, Lapinsbi H,Coletle C, et al. Contributions of fasting andpostprandial plasma glucose increments to the overall diurnal hypergly-cemia of type 2 diabetic patients: variationswith increasing levels of HbA1c[J]. Diabetes Care, 2003,26 (3) :881-885.
10Enc FY,Imerylyuz N,Akin L,et al.Inhibition of gastric emptyingby acarbose is correlated with GLP-1 response and accompaniedby CCK release[J].Am J Physiol Gastrointest Liver Physiol,2001,281(3):752-763.